Presenter: Jennifer Doudna, PhD
Professor of Chemistry, Biochemistry & Molecular Biology
Li Ka Shing Chancellor’s Professor in Biomedical and Health
University of California, Berkeley
Gene editing with CRISPR technology is transforming biology. Understanding the underlying chemical mechanisms of RNA-guided DNA and RNA cleavage provides a foundation for both conceptual advances and technology development. I will discuss how bacterial CRISPR adaptive immune systems inspire creation of powerful genome editing tools, enabling advances in both fundamental biology and applications in medicine. I will also discuss the ethical challenges of some of these applications with a focus on what our decisions now might mean for future generations.
As an internationally renowned professor of Chemistry and Molecular and Cell Biology at U.C. Berkeley, Doudna and her colleagues rocked the research world in 2012 by describing a simple way of editing the DNA of any organism using an RNA-guided protein found in bacteria. This technology, called CRISPR-Cas9, has opened the floodgates of possibility for human and non-human applications of gene editing, including assisting researchers in the fight against HIV, sickle cell disease and muscular dystrophy. Doudna is an Investigator with the Howard Hughes Medical Institute and a member of the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors and the American Academy of Arts and Sciences. She is also a Foreign Member of the Royal Society, and has received many other honors including the Kavli Prize, the Breakthrough Prize in Life Sciences, the Heineken Prize, the BBVA Foundation Frontiers of Knowledge Award and the Japan Prize. She is the co-author with Sam Sternberg of “A Crack in Creation,” a personal account of her research and the societal and ethical implications of gene editing.
For further information: http://med.stanford.edu/radiology/imagining-the-future.html .
Please note this seminar is now cancelled and will be rescheduled for a future date. Please contact Ashley Williams (ashleylw@stanford.edu) with any questions or concerns. Thank you for your understanding!
Presenter: Elias Zerhouni, MD
Professor Emeritus
John Hopkins University
Abstract
In a career that spanned academia as a physician scientist, government as director of the NIH and then president of R&D for a global pharmaceutical company I share my experience and lessons learned on the way. While different in essence, academia, government and industry have symbiotic and complementary roles. The geopolitics of Research and development across the globe will be presented and their implications for biomedicine will be discussed along with the key emerging trends shaping the research agenda in the years to come across the changing landscape of healthcare. Personal advice on how best to navigate one’s career in these different environments will be shared.
About
Elias Zerhouni, M.D., Professor Emeritus Radiology and Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Dr. Zerhouni was most recently the President, Global Research & Development, and a member of the Executive Committee for Sanofi from January 2011 to July 2018.
Dr. Zerhouni’s academic career was spent at the Johns Hopkins University and Hospital where he was professor of Radiology and Biomedical engineering and senior adviser for Johns Hopkins Medicine. He served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the School of Medicine from 1996 to 2002 before his appointment as Director of the National Institutes of Health from 2002 to 2008. In that position he oversaw the NIH’s 27 Institutes and Centers with more than 18,000 employees and a budget of $29.5 billion (2008).
In November 2009, President Obama appointed Dr. Zerhouni as one of the first presidential U.S. science envoys.
Dr. Zerhouni also served as senior fellow to the Bill and Melinda Gates foundation from 2009 to 2010 and senior advisor to the CEO of Sanofi.
Dr. Zerhouni has founded or co-founded five start-up companies, authored more than 200 publications and holds several patents. He has assumed positions on several Boards, including most recently, the board of the Lasker Foundation, Research!America and the NIH Foundation. He is also a member of the U.S. National Academy of Medicine and the U.S. National Academy of Engineering. He received the prestigious Legion of Honor medal from the French National Order in 2008, and was elected in 2010 as a member of the French Academy of Medicine and appointed as Chair of Innovation at the College de France in 2011.
For further information: http://med.stanford.edu/radiology/imagining-the-future.html .
2021 Virtual Gambhir Symposium
Monday, July 19, 2021 8:30 AM – 4:00 PM, PDT
Dr. Sanjiv Sam Gambhir was a visionary who had a profound impact on the world of science and humanity. As a leader and pioneer in the fields of molecular imaging, early detection of cancer, and precision health, his enduring legacy can be seen in the research and innovations continuing in these fields today.
The Gambhir Symposium aims to celebrate Dr. Gambhir’s illustrious career and continue down the paths he forged by highlighting the work still ongoing in the fields he helped to cultivate. Join us to hear researchers and collaborators share current thoughts and future outlooks on topics developed with Sam.
We hope you can join us for the 2021 Virtual Gambhir Symposium. Register here.
The agenda and speaker information are available on the Gambhir Symposium website. The event is fully virtual and the livestream link will be posted on the website closer to the event.
Click HERE to Register!
Presenter: Kiera Davis, RN, BSN
The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff. We have invited highly experienced Clinical research Education Program Manager, Kiera Davis, RN, BSN, to present on the important topic of Protocol adherence, Noncompliance and protocol deviations.
At the conclusion of this class, you will be able to:
• Identify Investigator Responsibilities
• Understand Protocol Deviations and Proper Deviation Process
• Recognize Types of Deviations
• Demonstrate Understanding of Common Deviations Related to AE/SAE Reporting
• Review Examples and Case Studies
Attendance is open to all research staff
About the Instructor:
Kiera Davis, RN, BSN joined Stanford University in 2015 and is the Education Program Manager in the Stanford Center for Clinical Research. She has worked in clinical research for 10 years at Stanford University and at the Duke Clinical Research Institute. Kiera obtained a BA in History from Boston University in 2006 followed by a BS in Nursing from Duke University. She worked as a Clinical Nurse II in the pediatric cardiac intensive care unit at Duke Hospital followed by two years as a travel nurse, working at Children’s Hospital of Los Angeles, Colorado Children’s in Denver, CO, Stanford Children’s Hospital, and Seattle Children’s Hospital. She is currently working towards a Master’s of Science in Clinical Research from Campbell University with projected graduation in Spring 2022.
BRN OPTIONAL
Spectrum is an approved provider by the California Board of Registered Nursing, Provider Number CEP15435 for 2 contact hour(s).
To receive your certificate with BRN credit, you are required to complete an evaluation at the conclusion of this class.
BRN Cancellation Policy: If you wish to cancel your registration, please contact Susan Saba at ssaba@stanford.edu.